DoJ to query Phase Forward about Oracle acquisition; dDugmakers opt for enterprise single sign-on;

> The U.S. Department of Justice asked Phase Forward for additional information as it reviews the effect of the company's acquisition by software giant Oracle on competition in the software market. Story

> Two drug companies--a combined 15,000 users--are using the Evidian Enterprise Single Sign-on (SSO) solution, which incorporates BIO-key International's biometric software. Announcement

> Drugmakers who hire third-party service providers to monitor such closed patient social networks as PatientsLikeMe should do so in an open and transparent way. Article

> Sentrx launches CROplus to help drug sponsors integrate pharmacovigilance with global clinical development. Release

> A standalone online query management system that tracks and monitors data discrepancies occuring during clinical trials is available from Clinovo. Release